Sanofi India announced that it has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for Beyfortus. Beyfortus is intended to prevent Respiratory...
Pharmaceutical major Lupin announced on Wednesday, June 5, that its European subsidiary has completed the acquisition of two brands from Sanofi. In its regulatory filing,...
Shares of Sanofi India Ltd and Cipla Ltd were trading 5.4% and 1.6% higher on 27 March after the companies announced signing a distribution agreement...
Shares of Sanofi India rose 5.5% on February 27, extending gains into the second session on strong quarterly earnings. Shares of the pharmaceutical company were...
A Memorandum of Understanding (MoU) has been signed by Sanofi India with National Institute of Pharmaceutical Education and Research (NIPER) Kolkata for promoting academic excellence...